ID   SC6A5_HUMAN             Reviewed;         797 AA.
AC   Q9Y345; O95288; Q4VAM7; Q9BX77;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Sodium- and chloride-dependent glycine transporter 2;
DE            Short=GlyT-2;
DE            Short=GlyT2;
DE   AltName: Full=Solute carrier family 6 member 5;
GN   Name=SLC6A5; Synonyms=GLYT2, NET1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   VARIANTS SER-124 AND GLY-162.
RX   PubMed=9845349; DOI=10.1016/S0014-5793(98)01390-8;
RA   Morrow J.A., Collie I.T., Dunbar D.R., Walker G.B., Shahid M.,
RA   Hill D.R.;
RT   "Molecular cloning and functional expression of the human glycine
RT   transporter GlyT2 and chromosomal localisation of the gene in the
RT   human genome.";
RL   FEBS Lett. 439:334-340(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   VARIANTS SER-102; SER-124 AND GLY-162.
RC   TISSUE=Spinal cord;
RX   PubMed=10381548; DOI=10.1016/S0169-328X(99)00135-7;
RA   Gallagher M.J., Burgess L.H., Brunden K.R.;
RT   "Characterization of multiple forms of the human glycine transporter
RT   type-2.";
RL   Brain Res. Mol. Brain Res. 70:101-115(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   VARIANTS SER-124; GLY-162; ARG-184; ASN-463 AND ALA-751.
RC   TISSUE=Spinal cord;
RX   PubMed=10606742; DOI=10.1016/S0014-5793(99)01636-1;
RA   Evans J., Herdon H., Cairns W., O'Brien E., Chapman C., Terrett J.,
RA   Gloger I.;
RT   "Cloning, functional characterisation and population analysis of a
RT   variant form of the human glycine type 2 transporter.";
RL   FEBS Lett. 463:301-306(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SER-124 AND GLY-162.
RA   Luyten W.;
RT   "Cloning and expression of a human glycine transporter type II.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS SER-124 AND
RP   GLY-162.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANTS HKPX3 VAL-306; MET-425; CYS-482; CYS-491; SER-509 AND
RP   ARG-510, VARIANT GLU-89, CHARACTERIZATION OF VARIANTS HKPX3 VAL-306;
RP   MET-425; CYS-482; CYS-491; SER-509 AND ARG-510, AND CHARACTERIZATION
RP   OF VARIANT GLU-89.
RX   PubMed=16751771; DOI=10.1038/ng1814;
RA   Rees M.I., Harvey K., Pearce B.R., Chung S.K., Duguid I.C., Thomas P.,
RA   Beatty S., Graham G.E., Armstrong L., Shiang R., Abbott K.J.,
RA   Zuberi S.M., Stephenson J.B., Owen M.J., Tijssen M.A.,
RA   van den Maagdenberg A.M., Smart T.G., Supplisson S., Harvey R.J.;
RT   "Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic
RT   component of human startle disease.";
RL   Nat. Genet. 38:801-806(2006).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] GLU-632.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Terminates the action of glycine by its high affinity
CC       sodium-dependent reuptake into presynaptic terminals. May be
CC       responsible for the termination of neurotransmission at
CC       strychnine-sensitive glycinergic synapses.
CC       {ECO:0000269|PubMed:10381548, ECO:0000269|PubMed:10606742,
CC       ECO:0000269|PubMed:9845349}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10381548,
CC       ECO:0000269|PubMed:10606742, ECO:0000269|PubMed:9845349}; Multi-
CC       pass membrane protein {ECO:0000250|UniProtKB:Q7K4Y6}.
CC   -!- TISSUE SPECIFICITY: Expressed in medulla, and to a lesser extent
CC       in spinal cord and cerebellum.
CC   -!- DISEASE: Hyperekplexia 3 (HKPX3) [MIM:614618]: A neurologic
CC       disorder characterized by neonatal hypertonia, an exaggerated
CC       startle response to tactile or acoustic stimuli, and life-
CC       threatening neonatal apnea episodes. Notably, in some cases,
CC       symptoms resolved in the first year of life.
CC       {ECO:0000269|PubMed:16751771}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF)
CC       (TC 2.A.22) family. SLC6A5 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF085412; AAC95145.1; -; mRNA.
DR   EMBL; AF142501; AAD27892.1; -; mRNA.
DR   EMBL; AF352733; AAK29670.1; -; mRNA.
DR   EMBL; AF117999; AAK12641.1; -; mRNA.
DR   EMBL; AC090707; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096319; AAH96319.1; -; mRNA.
DR   CCDS; CCDS7854.1; -.
DR   RefSeq; NP_001305298.1; NM_001318369.1.
DR   RefSeq; NP_004202.3; NM_004211.4.
DR   UniGene; Hs.136557; -.
DR   ProteinModelPortal; Q9Y345; -.
DR   BioGrid; 114599; 12.
DR   STRING; 9606.ENSP00000434364; -.
DR   BindingDB; Q9Y345; -.
DR   ChEMBL; CHEMBL3060; -.
DR   DrugBank; DB00145; Glycine.
DR   GuidetoPHARMACOLOGY; 936; -.
DR   TCDB; 2.A.22.2.10; the neurotransmitter:sodium symporter (nss) family.
DR   iPTMnet; Q9Y345; -.
DR   PhosphoSitePlus; Q9Y345; -.
DR   BioMuta; SLC6A5; -.
DR   DMDM; 296452967; -.
DR   PaxDb; Q9Y345; -.
DR   PeptideAtlas; Q9Y345; -.
DR   PRIDE; Q9Y345; -.
DR   Ensembl; ENST00000525748; ENSP00000434364; ENSG00000165970.
DR   GeneID; 9152; -.
DR   KEGG; hsa:9152; -.
DR   UCSC; uc001mqd.4; human.
DR   CTD; 9152; -.
DR   DisGeNET; 9152; -.
DR   GeneCards; SLC6A5; -.
DR   GeneReviews; SLC6A5; -.
DR   H-InvDB; HIX0035860; -.
DR   HGNC; HGNC:11051; SLC6A5.
DR   MalaCards; SLC6A5; -.
DR   MIM; 604159; gene.
DR   MIM; 614618; phenotype.
DR   neXtProt; NX_Q9Y345; -.
DR   OpenTargets; ENSG00000165970; -.
DR   Orphanet; 3197; Hereditary hyperekplexia.
DR   PharmGKB; PA35911; -.
DR   eggNOG; KOG3659; Eukaryota.
DR   eggNOG; COG0733; LUCA.
DR   GeneTree; ENSGT00760000118857; -.
DR   HOGENOM; HOG000116406; -.
DR   HOVERGEN; HBG071421; -.
DR   InParanoid; Q9Y345; -.
DR   KO; K05038; -.
DR   OMA; GNALHCK; -.
DR   OrthoDB; EOG091G08PX; -.
DR   PhylomeDB; Q9Y345; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-HSA-442660; Na+/Cl- dependent neurotransmitter transporters.
DR   GeneWiki; Glycine_transporter_2; -.
DR   GenomeRNAi; 9152; -.
DR   PRO; PR:Q9Y345; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000165970; -.
DR   CleanEx; HS_NET1; -.
DR   CleanEx; HS_SLC6A5; -.
DR   ExpressionAtlas; Q9Y345; baseline and differential.
DR   Genevisible; Q9Y345; HS.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:FlyBase.
DR   GO; GO:0015375; F:glycine:sodium symporter activity; IDA:FlyBase.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005328; F:neurotransmitter:sodium symporter activity; IEA:InterPro.
DR   GO; GO:0007268; P:chemical synaptic transmission; TAS:ProtInc.
DR   GO; GO:0036233; P:glycine import; IDA:FlyBase.
DR   GO; GO:0060012; P:synaptic transmission, glycinergic; IMP:FlyBase.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   PANTHER; PTHR11616; PTHR11616; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Disulfide bond;
KW   Glycoprotein; Membrane; Metal-binding; Neurotransmitter transport;
KW   Phosphoprotein; Polymorphism; Reference proteome; Sodium; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    797       Sodium- and chloride-dependent glycine
FT                                transporter 2.
FT                                /FTId=PRO_0000214762.
FT   TOPO_DOM      1    199       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical; Name=1. {ECO:0000255}.
FT   TRANSMEM    228    247       Helical; Name=2. {ECO:0000255}.
FT   TRANSMEM    271    291       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    292    393       Extracellular. {ECO:0000255}.
FT   TRANSMEM    394    412       Helical; Name=4. {ECO:0000255}.
FT   TRANSMEM    421    438       Helical; Name=5. {ECO:0000255}.
FT   TRANSMEM    474    491       Helical; Name=6. {ECO:0000255}.
FT   TRANSMEM    503    524       Helical; Name=7. {ECO:0000255}.
FT   TRANSMEM    557    576       Helical; Name=8. {ECO:0000255}.
FT   TRANSMEM    604    622       Helical; Name=9. {ECO:0000255}.
FT   TRANSMEM    638    658       Helical; Name=10. {ECO:0000255}.
FT   TRANSMEM    679    698       Helical; Name=11. {ECO:0000255}.
FT   TRANSMEM    717    735       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    736    797       Cytoplasmic. {ECO:0000255}.
FT   METAL       206    206       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       208    208       Sodium 2; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       209    209       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       213    213       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       477    477       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       509    509       Sodium 2. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       574    574       Sodium 1; via carbonyl oxygen.
FT                                {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   METAL       577    577       Sodium 1. {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   MOD_RES      56     56       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P58295}.
FT   MOD_RES      57     57       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q761V0}.
FT   MOD_RES      84     84       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q761V0}.
FT   CARBOHYD    343    343       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    353    353       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    364    364       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    311    320       {ECO:0000250|UniProtKB:Q7K4Y6}.
FT   VARIANT      89     89       A -> E (no effect on subcellular
FT                                location; no effect on glycine transport;
FT                                dbSNP:rs61736602).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044163.
FT   VARIANT     102    102       G -> S (in dbSNP:rs1443547).
FT                                {ECO:0000269|PubMed:10381548}.
FT                                /FTId=VAR_044164.
FT   VARIANT     124    124       F -> S (in dbSNP:rs1443548).
FT                                {ECO:0000269|PubMed:10381548,
FT                                ECO:0000269|PubMed:10606742,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9845349,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_044165.
FT   VARIANT     132    132       A -> G (in dbSNP:rs34243519).
FT                                /FTId=VAR_044166.
FT   VARIANT     162    162       A -> G (in dbSNP:rs1443549).
FT                                {ECO:0000269|PubMed:10381548,
FT                                ECO:0000269|PubMed:10606742,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9845349,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_044167.
FT   VARIANT     184    184       Q -> R. {ECO:0000269|PubMed:10606742}.
FT                                /FTId=VAR_011591.
FT   VARIANT     306    306       L -> V (in HKPX3; compound heterozygote
FT                                with S-509; impairment of glycine
FT                                transport when coexpressed with S-509 in
FT                                vitro; dbSNP:rs121908496).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044168.
FT   VARIANT     425    425       T -> M (in HKPX3; no effect on
FT                                subcellular location; impairs glycine
FT                                transport; dbSNP:rs121908498).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044169.
FT   VARIANT     457    457       K -> N (in dbSNP:rs3740870).
FT                                /FTId=VAR_044170.
FT   VARIANT     463    463       D -> N (in dbSNP:rs1805091).
FT                                {ECO:0000269|PubMed:10606742}.
FT                                /FTId=VAR_011592.
FT   VARIANT     482    482       W -> C (in HKPX3; no effect on
FT                                subcellular location; impairs glycine
FT                                transport).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044171.
FT   VARIANT     491    491       Y -> C (in HKPX3; no effect on
FT                                subcellular location; impairs glycine
FT                                transport; dbSNP:rs121908494).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044172.
FT   VARIANT     499    499       Y -> F (in dbSNP:rs7944684).
FT                                /FTId=VAR_044173.
FT   VARIANT     509    509       N -> S (in HKPX3; compound heterozygote
FT                                with V-306; no effect on subcellular
FT                                location; impairs glycine transport;
FT                                dbSNP:rs121908497).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044174.
FT   VARIANT     510    510       S -> R (in HKPX3; results in the
FT                                formation of large aggregates in the
FT                                cytoplasm; impairs glycine transport;
FT                                dbSNP:rs281864926).
FT                                {ECO:0000269|PubMed:16751771}.
FT                                /FTId=VAR_044175.
FT   VARIANT     632    632       V -> E (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036160.
FT   VARIANT     751    751       V -> A. {ECO:0000269|PubMed:10606742}.
FT                                /FTId=VAR_011593.
FT   VARIANT     767    767       G -> R (in dbSNP:rs16906628).
FT                                /FTId=VAR_044176.
FT   CONFLICT     24     24       G -> S (in Ref. 2; AAD27892).
FT                                {ECO:0000305}.
FT   CONFLICT    155    155       S -> G (in Ref. 2; AAD27892).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       N -> D (in Ref. 2; AAD27892).
FT                                {ECO:0000305}.
FT   CONFLICT    362    362       Q -> L (in Ref. 2; AAD27892).
FT                                {ECO:0000305}.
FT   CONFLICT    582    582       T -> S (in Ref. 2; AAD27892).
FT                                {ECO:0000305}.
SQ   SEQUENCE   797 AA;  87434 MW;  47D8A9B179896CE0 CRC64;
     MDCSAPKEMN KLPANSPEAA AAQGHPDGPC APRTSPEQEL PAAAAPPPPR VPRSASTGAQ
     TFQSADARAC EAERPGVGSC KLSSPRAQAA SAALRDLREA QGAQASPPPG SSGPGNALHC
     KIPFLRGPEG DANVSVGKGT LERNNTPVVG WVNMSQSTVV LATDGITSVL PGSVATVATQ
     EDEQGDENKA RGNWSSKLDF ILSMVGYAVG LGNVWRFPYL AFQNGGGAFL IPYLMMLALA
     GLPIFFLEVS LGQFASQGPV SVWKAIPALQ GCGIAMLIIS VLIAIYYNVI ICYTLFYLFA
     SFVSVLPWGS CNNPWNTPEC KDKTKLLLDS CVISDHPKIQ IKNSTFCMTA YPNVTMVNFT
     SQANKTFVSG SEEYFKYFVL KISAGIEYPG EIRWPLALCL FLAWVIVYAS LAKGIKTSGK
     VVYFTATFPY VVLVILLIRG VTLPGAGAGI WYFITPKWEK LTDATVWKDA ATQIFFSLSA
     AWGGLITLSS YNKFHNNCYR DTLIVTCTNS ATSIFAGFVI FSVIGFMANE RKVNIENVAD
     QGPGIAFVVY PEALTRLPLS PFWAIIFFLM LLTLGLDTMF ATIETIVTSI SDEFPKYLRT
     HKPVFTLGCC ICFFIMGFPM ITQGGIYMFQ LVDTYAASYA LVIIAIFELV GISYVYGLQR
     FCEDIEMMIG FQPNIFWKVC WAFVTPTILT FILCFSFYQW EPMTYGSYRY PNWSMVLGWL
     MLACSVIWIP IMFVIKMHLA PGRFIERLKL VCSPQPDWGP FLAQHRGERY KNMIDPLGTS
     SLGLKLPVKD LELGTQC
//
